BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 18535662)

  • 41. N-Myc regulates a widespread euchromatic program in the human genome partially independent of its role as a classical transcription factor.
    Cotterman R; Jin VX; Krig SR; Lemen JM; Wey A; Farnham PJ; Knoepfler PS
    Cancer Res; 2008 Dec; 68(23):9654-62. PubMed ID: 19047142
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The estrogen and c-Myc target gene HSPC111 is over-expressed in breast cancer and associated with poor patient outcome.
    Butt AJ; Sergio CM; Inman CK; Anderson LR; McNeil CM; Russell AJ; Nousch M; Preiss T; Biankin AV; Sutherland RL; Musgrove EA
    Breast Cancer Res; 2008; 10(2):R28. PubMed ID: 18373870
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of MYC-regulated long noncoding RNAs in cell cycle regulation and tumorigenesis.
    Kim T; Jeon YJ; Cui R; Lee JH; Peng Y; Kim SH; Tili E; Alder H; Croce CM
    J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25663692
    [TBL] [Abstract][Full Text] [Related]  

  • 44. circCTIC1 promotes the self-renewal of colon TICs through BPTF-dependent c-Myc expression.
    Zhan W; Liao X; Wang Y; Li L; Li J; Chen Z; Tian T; He J
    Carcinogenesis; 2019 Jun; 40(4):560-568. PubMed ID: 30403769
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mnt-deficient mammary glands exhibit impaired involution and tumors with characteristics of myc overexpression.
    Toyo-oka K; Bowen TJ; Hirotsune S; Li Z; Jain S; Ota S; Escoubet-Lozach L; Garcia-Bassets I; Lozach J; Rosenfeld MG; Glass CK; Eisenman R; Ren B; Hurlin P; Wynshaw-Boris A
    Cancer Res; 2006 Jun; 66(11):5565-73. PubMed ID: 16740691
    [TBL] [Abstract][Full Text] [Related]  

  • 46. c-Myc represses FOXO3a-mediated transcription of the gene encoding the p27(Kip1) cyclin dependent kinase inhibitor.
    Chandramohan V; Mineva ND; Burke B; Jeay S; Wu M; Shen J; Yang W; Hann SR; Sonenshein GE
    J Cell Biochem; 2008 Aug; 104(6):2091-106. PubMed ID: 18393360
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of tyrosine kinase, HCK, and tumor suppressor, BIN1, as potential mediators of AHI-1 oncogene in primary and transformed CTCL cells.
    Kennah E; Ringrose A; Zhou LL; Esmailzadeh S; Qian H; Su MW; Zhou Y; Jiang X
    Blood; 2009 May; 113(19):4646-55. PubMed ID: 19211505
    [TBL] [Abstract][Full Text] [Related]  

  • 48. SATB1 Promotes Pancreatic Cancer Growth and Invasion Depending on MYC Activation.
    Chen Z; Li Z; Li W; Zong Y; Zhu Y; Miao Y; Xu Z
    Dig Dis Sci; 2015 Nov; 60(11):3304-17. PubMed ID: 26108419
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Protein arginine methyltransferase 5 represses tumor suppressor miRNAs that down-regulate CYCLIN D1 and c-MYC expression in aggressive B-cell lymphoma.
    Karkhanis V; Alinari L; Ozer HG; Chung J; Zhang X; Sif S; Baiocchi RA
    J Biol Chem; 2020 Jan; 295(5):1165-1180. PubMed ID: 31822509
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Developmental context determines latency of MYC-induced tumorigenesis.
    Beer S; Zetterberg A; Ihrie RA; McTaggart RA; Yang Q; Bradon N; Arvanitis C; Attardi LD; Feng S; Ruebner B; Cardiff RD; Felsher DW
    PLoS Biol; 2004 Nov; 2(11):e332. PubMed ID: 15455033
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of MYC attenuates tumor cell self-renewal and promotes senescence in SMARCB1-deficient Group 2 atypical teratoid rhabdoid tumors to suppress tumor growth in vivo.
    Alimova I; Pierce A; Danis E; Donson A; Birks DK; Griesinger A; Foreman NK; Santi M; Soucek L; Venkataraman S; Vibhakar R
    Int J Cancer; 2019 Apr; 144(8):1983-1995. PubMed ID: 30230537
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Noncanonical regulation of the Hedgehog mediator GLI1 by c-MYC in Burkitt lymphoma.
    Yoon JW; Gallant M; Lamm ML; Iannaccone S; Vieux KF; Proytcheva M; Hyjek E; Iannaccone P; Walterhouse D
    Mol Cancer Res; 2013 Jun; 11(6):604-15. PubMed ID: 23525267
    [TBL] [Abstract][Full Text] [Related]  

  • 53. TGFβ-dependent gene expression shows that senescence correlates with abortive differentiation along several lineages in Myc-induced lymphomas.
    Müller J; Samans B; van Riggelen J; Fagà G; Peh K N R; Wei CL; Müller H; Amati B; Felsher D; Eilers M
    Cell Cycle; 2010 Dec; 9(23):4622-6. PubMed ID: 21127397
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Bromodomain Inhibitor JQ1 and the Histone Deacetylase Inhibitor Panobinostat Synergistically Reduce N-Myc Expression and Induce Anticancer Effects.
    Shahbazi J; Liu PY; Atmadibrata B; Bradner JE; Marshall GM; Lock RB; Liu T
    Clin Cancer Res; 2016 May; 22(10):2534-44. PubMed ID: 26733615
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Different promoter affinities account for specificity in MYC-dependent gene regulation.
    Lorenzin F; Benary U; Baluapuri A; Walz S; Jung LA; von Eyss B; Kisker C; Wolf J; Eilers M; Wolf E
    Elife; 2016 Jul; 5():. PubMed ID: 27460974
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metastasis-associated protein 1 (MTA1) is an essential downstream effector of the c-MYC oncoprotein.
    Zhang XY; DeSalle LM; Patel JH; Capobianco AJ; Yu D; Thomas-Tikhonenko A; McMahon SB
    Proc Natl Acad Sci U S A; 2005 Sep; 102(39):13968-73. PubMed ID: 16172399
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Deptor Is a Novel Target of Wnt/β-Catenin/c-Myc and Contributes to Colorectal Cancer Cell Growth.
    Wang Q; Zhou Y; Rychahou P; Harris JW; Zaytseva YY; Liu J; Wang C; Weiss HL; Liu C; Lee EY; Evers BM
    Cancer Res; 2018 Jun; 78(12):3163-3175. PubMed ID: 29666061
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Omomyc Reveals New Mechanisms To Inhibit the MYC Oncogene.
    Demma MJ; Mapelli C; Sun A; Bodea S; Ruprecht B; Javaid S; Wiswell D; Muise E; Chen S; Zelina J; Orvieto F; Santoprete A; Altezza S; Tucci F; Escandon E; Hall B; Ray K; Walji A; O'Neil J
    Mol Cell Biol; 2019 Nov; 39(22):. PubMed ID: 31501275
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genetic analysis of Raf1, Mdm2, c-Myc, Cdc25a and Cdc25b proto-oncogenes in 2',3'-dideoxycytidine- and 1,3-butadiene-induced lymphomas in B6C3F1 mice.
    Zhuang S; Söderkvist P
    Mutat Res; 2000 Jul; 452(1):19-26. PubMed ID: 10894886
    [TBL] [Abstract][Full Text] [Related]  

  • 60. c-myc and N-myc promote active stem cell metabolism and cycling as architects of the developing brain.
    Wey A; Knoepfler PS
    Oncotarget; 2010 Jun; 1(2):120-30. PubMed ID: 20651942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.